Skip to main content
OpenTrials

Clinical trial condition

Bone Diseases, Endocrine

Explore clinical trials studying Bone Diseases, Endocrine. Study availability and eligibility vary by location and protocol.

350 public trials 32 recruiting studies
Refine in advanced search Browse all conditions

Bone Diseases, Endocrine trial results

Completed

Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency

NCT00191165

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +11 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Bari, Italy
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Bologna, Italy
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Catania, Italy
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Milan, Italy
View Trial Details
Completed

Open Label Extension Study Evaluating Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients

NCT00635765

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Republican Centre for Medical Rehabilitation and Water-therapy Minsk, Belarus
  • Semmelweis Egyetem Altalanos Orvostudomanyi Budapest, Hungary
  • Institue of Endocrinology "C.I Parhon" Bucharest Bucharest, Romania
  • Institute of Endocrinology, University Clinical Center Belgrade, Serbia
View Trial Details
Completed

Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients

NCT00616551

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Republican Centre for Medical Rehabilitation and Water-therapy Minsk, Belarus
  • Semmelweis Egyetem Általános Orvostudományi Budapest, Hungary
  • Institute of Endocrinology "C. I. Parhon" Bucharest Bucharest, Romania
  • Institute of Endocrinology, University Clinical Center Belgrade, Serbia
View Trial Details
Completed

Long Term Study With B2036-PEG

NCT00143416

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Pfizer Investigational Site Kobe, Hyogo PREF, Japan
  • Pfizer Investigational Site Kozukue-cho, Kouhoku-ku, Yokohama-shi, Kanagawa, Japan
  • Pfizer Investigational Site Kyoto, Japan
  • Pfizer Investigational Site Hamamatsu, Shizuoka, Japan
View Trial Details
Completed

Canadian Pegvisomant Compassionate Study In Acromegalic Patients

NCT00151437

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Pfizer Investigational Site Edmonton, Alberta, Canada
  • Pfizer Investigational Site Edmonton, Alberta, Canada
  • Pfizer Investigational Site Halifax, Nova Scotia, Canada
  • Pfizer Investigational Site Toronto, Ontario, Canada
View Trial Details
Completed

A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly

NCT00068042

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site Chicago, Illinois, United States
  • Pfizer Investigational Site Chicago, Illinois, United States
  • Pfizer Investigational Site Boston, Massachusetts, United States
View all 55 locations
View Trial Details

Related conditions